Nara Mizuho, Komatsuda Atsushi, Itoh Fumiko, Kaga Hajime, Saitoh Masaya, Togashi Masaru, Kameoka Yoshihiro, Wakui Hideki, Takahashi Naoto
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan.
Department of Life Science, Akita University Graduate School of Engineering Science, Japan.
Intern Med. 2017;56(10):1247-1252. doi: 10.2169/internalmedicine.56.7991. Epub 2017 May 15.
Thrombocytopenia, Anasarca, Fever, Reticulin fibrosis/Renal failure, and Organomegaly (TAFRO) syndrome is a recently described systemic inflammatory disorder characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly. It has an acute or subacute onset of unknown etiology, although some pathological features resemble those of multicentric Castleman disease. We here report two cases of TAFRO syndrome. The symptoms and pathological findings in these cases met the 2015 diagnostic criteria. Our cases showed high serum procalcitonin levels, suggesting bacterial infection as an onset trigger. In addition, Case 1 is the first case complicated with adrenal hemorrhaging. Case 2 is the second case of tocilizumab-resistant TAFRO syndrome successfully treated with rituximab.
血小板减少、全身性水肿、发热、网状纤维组织增生/肾衰竭和器官肿大(TAFRO)综合征是一种最近被描述的全身性炎症性疾病,其特征为血小板减少、全身性水肿、发热、网状纤维组织增生/肾衰竭和器官肿大。它具有急性或亚急性起病,病因不明,尽管一些病理特征与多中心Castleman病相似。我们在此报告2例TAFRO综合征病例。这些病例的症状和病理表现符合2015年诊断标准。我们的病例显示血清降钙素原水平升高,提示细菌感染是发病诱因。此外,病例1是首例并发肾上腺出血的病例。病例2是第二例用利妥昔单抗成功治疗的托珠单抗耐药性TAFRO综合征病例。